Skip to content
★ Sign in to follow
VA
Total declarations
49
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (39 ops.)
€211k

Latest filing published 14 May 2010 for Lineage Cell Therapeutics, Inc., €16k.

Insider track record

Disclosed buys
0
Disclosed sells
39
Signal history

No signal scores available.

Valeta A. Gregg: trading record in brief

This profile gathers the share dealings of Valeta A. Gregg in Lineage Cell Therapeutics, Inc. Between 1 July 2009 and 12 May 2010, the trades on record add up to 49 filings.

Every open-market trade on record is a sale: 39 sales worth €211k. Outside the open market, there are 10 option exercises. So far in 2010, the count stands at no purchases and 5 sales.

The latest filing, published on 14 May 2010, reports an option exercise of €16k in Lineage Cell Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Valeta A. Gregg

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations49 total

25 of 49 declarations